APA (7th ed.) Citation

Hanauer, S., O’Reilly, T., Lester, R., Slatkin, N., Lee, J., Franklin, H., . . . Israel, R. (2021). SAFETY OF AMISELIMOD IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY. Inflammatory bowel diseases, 27(Supplement_1), S1. https://doi.org/10.1093/ibd/izaa347.001

Chicago Style (17th ed.) Citation

Hanauer, Stephen, Terry O’Reilly, Robert Lester, Neal Slatkin, Jimin Lee, Howard Franklin, Angela Bulawski, and Robert Israel. "SAFETY OF AMISELIMOD IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY." Inflammatory Bowel Diseases 27, no. Supplement_1 (2021): S1. https://doi.org/10.1093/ibd/izaa347.001.

MLA (9th ed.) Citation

Hanauer, Stephen, et al. "SAFETY OF AMISELIMOD IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY." Inflammatory Bowel Diseases, vol. 27, no. Supplement_1, 2021, p. S1, https://doi.org/10.1093/ibd/izaa347.001.